NexGel (NXGL) Competitors

$0.61 +0.10 (+20.14%)

Closing price 04:00 PM Eastern

Extended Trading

$0.56 -0.05 (-8.13%)

As of 07:51 PM Eastern

NXGL vs. RVP, MODD, ZJYL, POAI, and IRIX

Should you buy NexGel stock or one of its competitors? MarketBeat compares NexGel with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with NexGel include Retractable Technologies (RVP), Modular Medical (MODD), Jin Medical International (ZJYL), Predictive Oncology (POAI), and IRIDEX (IRIX). These companies are all part of the "medical equipment" industry.

How does NexGel compare to Retractable Technologies?

NexGel (NASDAQ:NXGL) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

NexGel has a net margin of -28.54% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NexGel	-28.54%	-64.29%	-29.64%
Retractable Technologies	-41.11%	-17.15%	-9.33%

2.2% of NexGel shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 20.6% of NexGel shares are owned by insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NexGel has higher earnings, but lower revenue than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NexGel	$11.42M	0.49	-$3M	-$0.40	N/A
Retractable Technologies	$38.27M	0.53	-$7.01M	-$0.21	N/A

NexGel presently has a consensus target price of $2.00, indicating a potential upside of 225.79%. Given NexGel's stronger consensus rating and higher probable upside, analysts plainly believe NexGel is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, NexGel had 6 more articles in the media than Retractable Technologies. MarketBeat recorded 8 mentions for NexGel and 2 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 beat NexGel's score of -0.24 indicating that Retractable Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NexGel	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

NexGel has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market.

Summary

Retractable Technologies beats NexGel on 10 of the 16 factors compared between the two stocks.

How does NexGel compare to Modular Medical?

Modular Medical (NASDAQ:MODD) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

NexGel has higher revenue and earnings than Modular Medical. NexGel is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$18.82M	-$14.71	N/A
NexGel	$11.42M	0.49	-$3M	-$0.40	N/A

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by insiders. Comparatively, 20.6% of NexGel shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, NexGel had 8 more articles in the media than Modular Medical. MarketBeat recorded 8 mentions for NexGel and 0 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.00 beat NexGel's score of -0.24 indicating that Modular Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Modular Medical	Neutral
NexGel	Neutral

NexGel has a consensus target price of $2.00, indicating a potential upside of 225.79%. Given NexGel's stronger consensus rating and higher possible upside, analysts plainly believe NexGel is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Modular Medical has a net margin of 0.00% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-245.85%	-190.80%
NexGel	-28.54%	-64.29%	-29.64%

Modular Medical has a beta of 0.24, suggesting that its share price is 76% less volatile than the broader market. Comparatively, NexGel has a beta of 0.74, suggesting that its share price is 26% less volatile than the broader market.

Summary

NexGel beats Modular Medical on 11 of the 15 factors compared between the two stocks.

How does NexGel compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Jin Medical International has higher revenue and earnings than NexGel.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	0.86	$1.19M	N/A	N/A
NexGel	$11.42M	0.49	-$3M	-$0.40	N/A

Jin Medical International has a net margin of 0.00% compared to NexGel's net margin of -28.54%. Jin Medical International's return on equity of 0.00% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
NexGel	-28.54%	-64.29%	-29.64%

NexGel has a consensus target price of $2.00, suggesting a potential upside of 225.79%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Jin Medical International has a beta of 7.52, meaning that its stock price is 652% more volatile than the broader market. Comparatively, NexGel has a beta of 0.74, meaning that its stock price is 26% less volatile than the broader market.

2.2% of NexGel shares are held by institutional investors. 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, NexGel had 8 more articles in the media than Jin Medical International. MarketBeat recorded 8 mentions for NexGel and 0 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat NexGel's score of -0.24 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Neutral
NexGel	Neutral

Summary

Jin Medical International beats NexGel on 8 of the 14 factors compared between the two stocks.

How does NexGel compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

NexGel has higher revenue and earnings than Predictive Oncology. NexGel is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	9.54	-$12.66M	-$13.50	N/A
NexGel	$11.42M	0.49	-$3M	-$0.40	N/A

NexGel has a net margin of -28.54% compared to Predictive Oncology's net margin of -5,065.23%. NexGel's return on equity of -64.29% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
NexGel	-28.54%	-64.29%	-29.64%

NexGel has a consensus target price of $2.00, indicating a potential upside of 225.79%. Given NexGel's stronger consensus rating and higher probable upside, analysts clearly believe NexGel is more favorable than Predictive Oncology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Predictive Oncology has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, NexGel has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

9.0% of Predictive Oncology shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by insiders. Comparatively, 20.6% of NexGel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, NexGel had 7 more articles in the media than Predictive Oncology. MarketBeat recorded 8 mentions for NexGel and 1 mentions for Predictive Oncology. Predictive Oncology's average media sentiment score of 0.75 beat NexGel's score of -0.24 indicating that Predictive Oncology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Predictive Oncology	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NexGel	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

NexGel beats Predictive Oncology on 11 of the 16 factors compared between the two stocks.

How does NexGel compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and NexGel (NASDAQ:NXGL) are both small-cap medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, dividends, valuation and analyst recommendations.

IRIDEX has a net margin of -8.42% compared to NexGel's net margin of -28.54%. NexGel's return on equity of -64.29% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-8.42%	-1,204.74%	-14.39%
NexGel	-28.54%	-64.29%	-29.64%

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 2.2% of NexGel shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 20.6% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IRIDEX presently has a consensus target price of $3.00, indicating a potential upside of 185.71%. NexGel has a consensus target price of $2.00, indicating a potential upside of 225.79%. Given NexGel's higher probable upside, analysts plainly believe NexGel is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NexGel	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

NexGel has lower revenue, but higher earnings than IRIDEX. IRIDEX is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.35	-$4.44M	-$0.26	N/A
NexGel	$11.42M	0.49	-$3M	-$0.40	N/A

In the previous week, NexGel had 3 more articles in the media than IRIDEX. MarketBeat recorded 8 mentions for NexGel and 5 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.67 beat NexGel's score of -0.24 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NexGel	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IRIDEX has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, NexGel has a beta of 0.74, indicating that its stock price is 26% less volatile than the broader market.

Summary

NexGel beats IRIDEX on 8 of the 14 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NXGL vs. The Competition

Export

Metric	NexGel	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.67M	$6.99B	$6.25B	$12.23B
Dividend Yield	N/A	1.69%	2.80%	5.32%
P/E Ratio	-1.53	49.19	20.79	25.05
Price / Sales	0.49	70.19	531.21	72.69
Price / Cash	N/A	24.49	43.09	54.25
Price / Book	1.25	6.24	9.81	6.83
Net Income	-$3M	$158.81M	$3.55B	$335.69M
7 Day Performance	5.84%	-1.12%	-2.07%	-2.03%
1 Month Performance	-2.74%	-5.54%	-3.90%	-1.90%
1 Year Performance	-74.31%	-4.51%	29.39%	27.36%

NexGel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NXGL NexGel	1.6862 of 5 stars	$0.61 +20.1%	$2.00 +225.8%	-78.8%	$4.67M	$11.42M	N/A	10	Earnings Report Gap Up
RVP Retractable Technologies	N/A	$0.69 -4.3%	N/A	-6.9%	$20.75M	$38.27M	N/A	240	Gap Up
MODD Modular Medical	0.7588 of 5 stars	$3.91 -1.5%	N/A	-88.5%	$18.50M	N/A	N/A	20	Gap Up
ZJYL Jin Medical International	N/A	$2.30 -2.5%	N/A	-85.1%	$18.47M	$20.69M	N/A	245	Gap Down
POAI Predictive Oncology	0.1957 of 5 stars	$5.43 +4.4%	N/A	-63.9%	$18.43M	$1.66M	N/A	30	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NXGL) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NexGel (NXGL) Competitors

NXGL vs. RVP, MODD, ZJYL, POAI, and IRIX

How does NexGel compare to Retractable Technologies?

Summary

How does NexGel compare to Modular Medical?

Summary

How does NexGel compare to Jin Medical International?

Summary

How does NexGel compare to Predictive Oncology?

Summary

How does NexGel compare to IRIDEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NexGel (NXGL) Competitors

NXGL vs. RVP, MODD, ZJYL, POAI, and IRIX

How does NexGel compare to Retractable Technologies?

Is NXGL or RVP more profitable?

Do institutionals & insiders have more ownership in NXGL or RVP?

Which has stronger valuation & earnings, NXGL or RVP?

Do analysts recommend NXGL or RVP?

Does the media prefer NXGL or RVP?

Which has more risk and volatility, NXGL or RVP?

Summary

How does NexGel compare to Modular Medical?

Which has preferable valuation & earnings, MODD or NXGL?

Do insiders and institutionals believe in MODD or NXGL?

Does the media refer more to MODD or NXGL?

Do analysts rate MODD or NXGL?

Is MODD or NXGL more profitable?

Which has more volatility and risk, MODD or NXGL?

Summary

How does NexGel compare to Jin Medical International?

Which has stronger earnings and valuation, ZJYL or NXGL?

Is ZJYL or NXGL more profitable?

Do analysts recommend ZJYL or NXGL?

Which has more risk & volatility, ZJYL or NXGL?

Do institutionals and insiders have more ownership in ZJYL or NXGL?

Does the media favor ZJYL or NXGL?

Summary

How does NexGel compare to Predictive Oncology?

Which has better valuation & earnings, POAI or NXGL?

Is POAI or NXGL more profitable?

Do analysts recommend POAI or NXGL?

Which has more risk & volatility, POAI or NXGL?

Do insiders and institutionals believe in POAI or NXGL?

Does the media favor POAI or NXGL?

Summary

How does NexGel compare to IRIDEX?

Is IRIX or NXGL more profitable?

Do insiders & institutionals have more ownership in IRIX or NXGL?

Do analysts rate IRIX or NXGL?

Which has higher earnings and valuation, IRIX or NXGL?

Does the media favor IRIX or NXGL?

Which has more volatility & risk, IRIX or NXGL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NXGL vs. The Competition

NexGel Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools